Medications for Psychological and Behavioral Symptoms

Prescription

Journals

Gareri P. Cotroneo A. Lacava R. Seminara G. Marigliano N. Loiacono A. De Sarro G.(2004). Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD). Archives of Gerontology & Geriatrics - Supplement. (9):207-15.

Meguro K. Meguro M. Tanaka Y. Akanuma K. Yamaguchi K. Itoh M. (2004). Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease. [ Randomized controlled study] Journal of Geriatric Psychiatry & Neurology. 17(2):61-7.

Lawlor BA. (2004). Behavioral and psychological symptoms in dementia : the role of atypical antipsychotics. Journal of Clinical Psychiatry. 65 Suppl 11:5-10.

Ballard, C. & Margallo-Lano, M. (2004). The Relationship Between Antipsychotic Treatment and Quality of Life for Patients With Dementia Living in Residential and Nursing Home Care Facilities.Journal of Clinical Psychiatry. 65 Suppl 11:23-28.

Profenno LA. Tariot PN. (2004). Pharmacologic management of agitation in Alzheimer's disease. [Journal Article. Review] Dementia & Geriatric Cognitive Disorders. 17(1-2):65-77.

Tariot PN. Profenno LA. Ismail MS. (2004). Efficacy of atypical antipsychotics in elderly patients with dementia. [Journal Article. Review.] Journal of Clinical Psychiatry. 65 Suppl 11:11-5.

Katz, I. (2004). Optimizing atypical antipsychotics: Treatment strategies in the elderly, Journal of Gerontological Nursing, 52(12), S272-277.

Evans JG. Wilcock G. Birks J. (2004). Evidence-based pharmacotherapy of Alzheimer's disease. International Journal of Neuropsychopharmacology. 7(3):351-69.***

Winblad B. Brodaty H. Gauthier S. Morris JC. Orgogozo JM. Rockwood K. Schneider L. Takeda M. Tariot P. Wilkinson D. (2001). Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? International Journal of Geriatric Psychiatry. 16(7):653-66.

Tariot PN. Farlow MR. Grossberg GT. Graham SM. McDonald S. Gergel I. Memantine Study Group. (2004). Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. [Multicenter Study. Randomized Controlled Trial] JAMA. 291(3):317-24.

Cummings JL. Schneider L. Tariot PN. Kershaw PR. Yuan W. (2004). Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease. American Journal of Psychiatry. 161(3):532-8.

Hartmann S. Mobius HJ. (2003). Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy. [Journal Article] International Clinical Psychopharmacology. 18(2):81-5.

Herbals

Online

Includes commonly used herbals list with links to info., “Ask a pharmacist,” “Drugs to be used with caution in the elderly” www.agenet.com , go to Drugs, then Natural Herbal Remedies and Vitamins

Cognitive Enhancers

Prescription

Online

Cholinesterase inhibitors, dosages, side effects.
www.alzwell.com , go to Medications Fact Sheet

Journals

Evans JG. Wilcock G. Birks J. (2004). Evidence-based pharmacotherapy of Alzheimer's disease. International Journal of Neuropsychopharmacology. 7(3):351-69.***

Winblad B. Brodaty H. Gauthier S. Morris JC. Orgogozo JM. Rockwood K. Schneider L. Takeda M. Tariot P. Wilkinson D. (2001). Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? International Journal of Geriatric Psychiatry. 16(7):653-66.

Tariot PN. Farlow MR. Grossberg GT. Graham SM. McDonald S. Gergel I. Memantine Study Group. (2004). Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. [Multicenter Study. Randomized Controlled Trial] JAMA. 291(3):317-24.

Cummings JL. Schneider L. Tariot PN. Kershaw PR. Yuan W. (2004). Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease. American Journal of Psychiatry. 161(3):532-8.

Hartmann S. Mobius HJ. (2003). Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy. [Journal Article] International Clinical Psychopharmacology. 18(2):81-5.

Herbals

Online

Includes commonly used herbals list with links to info., “Ask a pharmacist,” “Drugs to be used with caution in the elderly” www.agenet.com, go to Drugs, then Natural Herbal Remedies and Vitamins

Cholinesterase inhibitors, dosages, side effects. www.alzwell.com, go to Medications Fact Sheet

Journal

Berman K. Brodaty H. (2004). Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders. [Journal Article. Review] CNS Drugs. 18(12):807-25.

Non-Pharmacological Strategies

Journals

Colling KB. Buettner LL. Simple pleasures. (2002). Interventions from the need-driven Dementia -Compromised Behavior model. [Journal Article. Multicenter Study] Journal of Gerontological Nursing . 28(10):16-20.

Phillips VL. Diwan S. Egner A. (2002).Development of a tool for assessment and care planning for dementia-related problem behaviors in home and community-based services programs: the Problem Behavior Inventory. Home Health Care Services Quarterly. 21(1):29-45.

Teri L. Logsdon RG. McCurry SM.(2002). Nonpharmacologic treatment of behavioral disturbance in dementia. [Review] [Journal Article. Review.] Medical Clinics of North America . 86(3):641-56, viii.